Chief Scientific Officer · Altimmune, Inc. · Common Stock, par value $0.0001
Side
M
Value
—
Shares
15.8K
Price
—
Executed
Jan 27, 2026
Disclosed
Jan 29, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jan 27 executedJan 29, 2026 disclosed
ALT · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+5 / 25
No reported dollar value · 18.8% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Roberts M Scot filed this Form 4 reporting a option exercise of ALT on Jan 27, 2026. It became public on Jan 29, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Scientific Officer
Roberts M Scotcik:0001705905
Issuer
Altimmune, Inc.cik:0001326190
Revision history · 0
No field has changed since this record was first ingested.
